Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 14, 2019 - Issue
Submit an article Journal homepage
136
Views
17
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

Dave Singh1 Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK, [email protected]Correspondence[email protected]
,
Leonardo M Fabbri2 Section of Cardiorespiratory and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy;3 COPD Center, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
,
Stefano Vezzoli4 Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy
,
Stefano Petruzzelli4 Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy
&
Alberto Papi2 Section of Cardiorespiratory and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
Pages 531-546 | Published online: 28 Feb 2019

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Joseph Tkacz, Kristin A Evans, Daniel R Touchette, Edward Portillo, Charlie Strange, Anthony Staresinic, Norbert Feigler, Sushma Patel & Michael Pollack. (2022) PRIMUS – Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 329-342.
Read now
Wen-Chien Cheng, Biing-Ru Wu, Wei-Chih Liao, Chih-Yu Chen, Wei-Chun Chen, Te-Chun Hsia, Chih-Yen Tu, Chia-Hung Chen & Wu-Huei Hsu. (2020) When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3375-3384.
Read now
Alberto Braghiroli, Fulvio Braido, Alessio Piraino, Paola Rogliani, Pierachille Santus & Nicola Scichilone. (2020) Day and Night Control of COPD and Role of Pharmacotherapy: A Review. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1269-1285.
Read now

Articles from other publishers (14)

Aldo Pezzuto, Giuseppe Tonini, Massimo Ciccozzi, Pierfilippo Crucitti, Michela D’Ascanio, Fiammetta Cosci, Antonella Tammaro, Antonella Di Sotto, Teresa Palermo, Elisabetta Carico & Alberto Ricci. (2022) Functional Benefit of Smoking Cessation and Triple Inhaler in Combustible Cigarette Smokers with Severe COPD: A Retrospective Study. Journal of Clinical Medicine 12:1, pages 234.
Crossref
Kristin A EvansMichael PollackEdward PortilloCharlie StrangeDaniel R TouchetteAnthony StaresinicSushma PatelJoseph TkaczNorbert Feigler. (2022) Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study. Journal of Managed Care & Specialty Pharmacy 28:12, pages 1366-1377.
Crossref
Mario Cazzola & Maria Gabriella Matera. (2022) Clinically important deterioration: a composite tool for managing patients with COPD. Respiratory Medicine 205, pages 107054.
Crossref
Chih-Cheng Lai, Chao-Hsien Chen, Kuang-Hung Chen, Cheng-Yi Wang, Tsan-Ming Huang, Ya-Hui Wang & Hao-Chien Wang. (2022) The Impact of 52-Week Single Inhaler Device Triple Therapy versus Dual Therapy on the Mortality of COPD Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Life 12:2, pages 173.
Crossref
Arnaud Bourdin, Nicolas Molinari, Gary T. Ferguson, Barinder Singh, Mohd Kashif Siddiqui, Ulf Holmgren, Mario Ouwens, Martin Jenkins & Enrico De Nigris. (2021) Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis. Advances in Therapy 38:6, pages 3089-3112.
Crossref
Mònica Monteagudo, Alexa Nuñez, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Miriam Barrecheguren, Dimitra Lambrelli & Marc Miravitlles. (2021) Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain. Archivos de Bronconeumología 57:3, pages 205-213.
Crossref
Mònica Monteagudo, Alexa Nuñez, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Miriam Barrecheguren, Dimitra Lambrelli & Marc Miravitlles. (2021) Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain. Archivos de Bronconeumología (English Edition) 57:3, pages 205-213.
Crossref
MeiLan K. Han, Gerard J. Criner, Mark T. Dransfield, David M.G. Halpin, Christine E. Jones, Sally Kilbride, Peter Lange, Sally Lettis, David A. Lipson, David A. Lomas, Neil Martin, Fernando J. Martinez, Robert A. Wise, Ian P. Naya & Dave Singh. (2021) Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis. ERJ Open Research 7:1, pages 00663-2020.
Crossref
Klaus F. Rabe, James D. Chalmers, Marc Miravitlles, Janwillem W. H. Kocks, Ioanna Tsiligianni, Alberto de la Hoz, Wenqiong Xue, Dave Singh, Gary T. Ferguson & Jadwiga Wedzicha. (2020) Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO® Trials. Advances in Therapy 38:1, pages 579-593.
Crossref
Dave Singh, Gerard J. Criner, Ian Naya, Paul W. Jones, Lee Tombs, David A. Lipson & MeiLan K. Han. (2020) Measuring disease activity in COPD: is clinically important deterioration the answer?. Respiratory Research 21:1.
Crossref
S. N. Avdeev, Z. R. Aisanov, V. V. Arkhipov, A. S. Belevskiy, I. V. Leshchenko, S. I. Ovcharenko, A. V. Emel'yanov, I. V. Demko, G. L. Ignatova, I. N. Trofimenko & E. I. Shmelev. (2020) Inhalation glucocorticosteroids in the treatment of chronic obstructive pulmonary disease. Russian Pulmonology 30:3, pages 330-343.
Crossref
Gary T. Ferguson, Patrick Darken, Shaila Ballal, Mohd Kashif Siddiqui, Barinder Singh, Sumeet Attri, Ulf Holmgren & Enrico de Nigris. (2020) Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis. Advances in Therapy 37:6, pages 2956-2975.
Crossref
Urmila P. Kodavanti. (2019) Susceptibility Variations in Air Pollution Health Effects: Incorporating Neuroendocrine Activation. Toxicologic Pathology 47:8, pages 962-975.
Crossref
Bronwyn Boyes. (2019) Building Hope by Restoring Breathing in Airways Diseases. EMJ Respiratory, pages 32-41.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.